Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures
- PMID: 8985706
- DOI: 10.1016/s0920-1211(96)00059-9
Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures
Abstract
Using immunocytochemistry and in situ hybridization analysis of mRNA, we investigated the changes in the expression of somatostatin and neuropeptide Y (NPY) in the rat hippocampal principal neurons in kindling or after electrically induced status epilepticus (SE), two models of limbic epilepsy associated with different chronic sequelae of seizures and seizure-related neuropathology. At the preconvulsive stage 2 of kindling and after three consecutive tonic-clonic seizures (stage 5) but not after a single-discharge (AD), somatostatin and NPY immunoreactivity (IR) were markedly increased in interneurons of the deep hilus and the polymorphic cell layer and their presumed projections to the outer molecular layer of the dentate gyrus. Increased mRNA levels were observed in the same neurons. NPY IR and mRNA were highly expressed in pyramidal-shaped basket cells at both stages of kindling. IR was similar two days after stages 2 or 5 of kindling while less pronounced effects were observed one week after kindling completion. Peptide-containing neurons in the hilus appeared well preserved in spite of an average of 24% reduction of Nissl stained cells (p < 0.01) in the stimulated and contralateral hippocampus at stage 5. No sprouting of mossy fibres in the inner molecular layer was found as assessed by Timm staining. Thirty days after SE, somatostatin IR was slightly reduced or similar to controls in the ventral dentate gyrus and molecular layer in four or six rats (SE-I group) while in the two other post-SE rats (SE-II), somatostatin IR was lost. These changes were associated with a different extent of neurodegeneration as assessed by cell counting of Nissl stained sections. In the granule cells/mossy fibres NPY-IR was transiently expressed at stage 2 and after a single AD. Differently, NPY-IR was persistently enhanced in the mossy fibres of all post-SE rats particularly in the SE-II group. In these rats, NPY immunoreactive fibres were detected in the infrapyramidal region of the stratum oriens CA3 and in the inner molecular layer of the dentate gyrus very likely labeling sprouted mossy fibres. In the hippocampus proper of kindled rats, somatostatin and NPY IR were respectively enhanced in the stratum lacunosum moleculare, the subiculum and in the alveus while no significant changes were observed after SE. Changes in peptide expression were bilateral and involved both the dorsal and the ventral hippocampus. The lasting modifications in peptides IR and mRNA expression in distinct neuronal populations of the hippocampus may reflect functional modifications neurons and play a role in limbic epileptogenesis.
Similar articles
-
Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis.Brain Res Brain Res Rev. 1996 Jun;22(1):27-50. Brain Res Brain Res Rev. 1996. PMID: 8871784 Review.
-
Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy.Neuroscience. 1995 Dec;69(3):831-45. doi: 10.1016/0306-4522(95)00268-n. Neuroscience. 1995. PMID: 8596652
-
Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat.Neuroscience. 1992 Oct;50(4):831-46. doi: 10.1016/0306-4522(92)90207-i. Neuroscience. 1992. PMID: 1360155
-
Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats.Eur J Neurosci. 1993 Oct 1;5(10):1312-20. doi: 10.1111/j.1460-9568.1993.tb00917.x. Eur J Neurosci. 1993. PMID: 7903891
-
Chronic epileptogenic cellular alterations in the limbic system after status epilepticus.Epilepsia. 1999;40 Suppl 1:S23-33; discussion S40-1. doi: 10.1111/j.1528-1157.1999.tb00875.x. Epilepsia. 1999. PMID: 10421558 Review.
Cited by
-
Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis.Brain Res. 2007 Jan 5;1127(1):151-62. doi: 10.1016/j.brainres.2006.09.107. Epub 2006 Nov 22. Brain Res. 2007. PMID: 17123484 Free PMC article.
-
Functional implications of seizure-induced neurogenesis.Adv Exp Med Biol. 2004;548:192-212. doi: 10.1007/978-1-4757-6376-8_14. Adv Exp Med Biol. 2004. PMID: 15250595 Free PMC article. Review.
-
Altered expression of neuropeptide Y receptors caused by focal cortical dysplasia in human intractable epilepsy.Oncotarget. 2016 Mar 29;7(13):15329-38. doi: 10.18632/oncotarget.7855. Oncotarget. 2016. PMID: 26943580 Free PMC article.
-
Compensatory Regulation of Excitation/Inhibition Balance in the Ventral Hippocampus: Insights from Fragile X Syndrome.Biology (Basel). 2025 Mar 31;14(4):363. doi: 10.3390/biology14040363. Biology (Basel). 2025. PMID: 40282228 Free PMC article. Review.
-
Neuropeptide Y: potential role in recurrent developmental seizures.Peptides. 2007 Feb;28(2):441-6. doi: 10.1016/j.peptides.2006.08.034. Epub 2006 Dec 29. Peptides. 2007. PMID: 17196709 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous